SB R&D
Executive Summary
SmithKline Beecham Chief Science & Technology Officer George Poste, MD, retires effective Oct. 31. Poste plans to move to California and will remain chairman of the Santa Clara-based diaDexus diagnostics business formed under a joint venture agreement between SB and Incyte in 1997